JTEC Resultados de beneficios anteriores
Pasado controles de criterios 1/6
JTEC's earnings have been declining at an average annual rate of -16.4%, while the Medical Equipment industry saw earnings growing at 7.8% annually. Revenues have been growing at an average rate of 5.3% per year. JTEC's return on equity is 7.4%, and it has net margins of 9.9%.
Información clave
-16.4%
Tasa de crecimiento de los beneficios
-16.5%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | 7.8% |
| Tasa de crecimiento de los ingresos | 5.3% |
| Rentabilidad financiera | 7.4% |
| Margen neto | 9.9% |
| Próxima actualización de resultados | 12 Nov 2024 |
Actualizaciones de resultados anteriores recientes
Desglose de ingresos y gastos
Cómo gana y gasta dinero JTEC. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 24 | 2,010 | 199 | 676 | 290 |
| 31 Mar 24 | 1,602 | -10 | 656 | 263 |
| 31 Dec 23 | 1,920 | 177 | 655 | 263 |
| 30 Sep 23 | 1,975 | 247 | 604 | 263 |
| 30 Jun 23 | 1,908 | 238 | 595 | 263 |
| 31 Mar 23 | 1,554 | 105 | 596 | 263 |
| 31 Dec 22 | 1,336 | 40 | 566 | 263 |
| 30 Sep 22 | 1,337 | 21 | 539 | 263 |
| 30 Jun 22 | 1,150 | -32 | 508 | 263 |
Ingresos de calidad: 3446 has high quality earnings.
Margen de beneficios creciente: 3446's current net profit margins (9.9%) are lower than last year (12.5%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Insufficient data to determine if 3446's year-on-year earnings growth rate was positive over the past 5 years.
Acelerando crecimiento: 3446's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Beneficios vs. Industria: 3446 had negative earnings growth (-16.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (5.7%).
Rentabilidad financiera
Alta ROE: 3446's Return on Equity (7.4%) is considered low.